Sept 2002 References
References
"Choosing Surface Disinfectants," by Kathryn Dix, page 14.
1. National Institutes of Health, Division of Safety. Biologicaldecontamination: methods of disinfection. www.nih.gov/od/ors/ds/pubs/biodecontamination/biodecon1.htm.08/07/02.
2. Crawford L, Yu Z, Keegan L, Yu T. A comparison of commonly used surfacedisinfectants. Infection Control Today. November 2000, 1-9.
3. OSHA. Frequently Asked Questions: Bloodborne Pathogens. www.osha-slc.gov/html/faq-bbp.html.08/07/02.
4. Centers for Disease Control and Prevention. Sterilization or disinfectionof patient-care equipment: HIV related. www.cdc.gov/ncidod/hip/Sterile/hivsteri.htm.08/07/02.
5. Rutala WA. APIC guideline for selection and use of disinfectants. Am JInfect Control. 1996;24:313-342.
6. Rutala WA, Weber DJ. New disinfection and sterilization methods. EmergingInfect Diseases. 2001; 7(2): 348-53.
7. www.surfacine.com. 08/06/02.
Battling Biofilm: Surface Science, Antimicrobials Help Combat MedicalDevice-Related Infections," by Kelly M. Pyrek, page 32.
1. Katz J. Coating and surface treatment technology. www.devicelink.com/mddi/archive/97/04/019.html.
2. Lin TL, et al. Antimicrobial coatings: a remedy for medical device-relatedinfections. www.medicaldevicesonline.com/features/story.epml?/features.REF=47.
3. Donlan RM. Biofilms and device-related infections. www.cdc.gov/ncidod/eid/vol7no2/donlan.htm.
4. Ibid.
5. Katz J. Coating and surface treatment technology. www.devicelink.com/mddi/archive/97/04/019.html.
6. Lin TL, et al. Antimicrobial coatings: a remedy for medical device-relatedinfections. www.medicaldevicesonline.com/features/story.epml?/features.REF=47.
7. Maki DG. Infections due to infusion therapy. In: Bennett JV, Brachman PS,eds. Hospital Infections. 3rd ed. Boston: Little, Brown; 1992.
8. Plott R, Polk B, Murdock B, et al. Mortality associated with nosocomialurinary tract infection. New Engl J Med. 30(11):637-642, 1982.
9. Watson SK, Lichtenberg DA, Wainwright H. Technology vs. the most commonnosocomial infection. Infection Control Today. www.infectioncontroltoday.com/articles/081topics.html.
10. Maki DG, Stolz SM, Wheeler S, Mermel LA. Prevention of central venouscatheter-related bloodstream infection by use of an antiseptic-impregnatedcatheter. Ann Intern Med. 1997;127:267-74.
11. Raad I, Darouiche R, Dupuis J, Abi-Said D, Gabrielli A, Hachem R, et al.Central venous catheters coated with minocycline and rifampin for the preventionof catheter-related colonization and bloodstream infections. Ann Intern Med.1997;127:267-74.
12. www.acponline.org/journals/annals/15aug97/cathedit.htm.
13. Davis RL and Etris SF. The development and functions of silver in waterpurification and disease control. The Silver Institute, Washington, D.C. www.silverfacts.org/pages/davies.html.
14. Silver-coated catheters cut infection. www.silverinstitute.org/silnews/1998/4b1998.htm.
15. Katz J. Coating and surface treatment technology. www.devicelink.com/mddi/archive/97/04/019.html
16. Rosenblatt AA and Knapp JE. Chlorine dioxide gas sterilization. HIMAConference Proceedings, pp 47-50.
"Fighting the Flu," by Susan Dolan, RN, MS, CIC, page 46
1. American Academy of Pediatrics. 2000 red book: report of the Committee onInfectious Diseases. 25th ed. Elk Grove Village, IL: American Academy ofPediatrics, 2000:351-9.
2. Bolyard EA, Tablan OC, Williams WW, et al., for the Hospital InfectionControl Practices Advisory Committee. Guideline for infection control in healthcare personnel. Am J Infect Control. 1998;26:289-354.
3. CDC. Prevention and control of influenza. Recommendations of the AdvisoryCommittee On Immunization Practices (ACIP). MMWR 2002; 51(RR03):1-31.
4. CDC. Delayed influenza vaccine availability for the 2001-02 season andsupplemental recommendations of the Advisory Committee on Immunization Practices[Notice to readers]. MMWR 2001;50:582-5.
5. Garner JS, for the Hospital Infection Control Practices AdvisoryCommittee. Guideline for isolation precautions in hospitals. Infect Control HospEpidemiol. 1996;17:53-80.
6. Hendrick JA, Barzilai A, Behre U, et al. Zanamivir for treatment ofsymptomatic influenza A and B infection in children five to twelve years of age:a randomized controlled trial. Pediatr Infect Dis J. 2000;19:410-17.
7. MIST (Management of Influenza in the Southern Hemisphere Trialists) StudyGroup. Randomised trial of efficacy and safety of inhaled zanamivir in treatmentof influenza A and B virus infections. Lancet. 1998;352:1877-81.
8. Monto AS, Fleming DM, Henry D, et al. Efficacy and safety of theneuraminidase inhibitor zanamivir in the treatment of influenza A and B virusinfections. J Infect Dis. 1999;180:254-61.
9. Neuzil KM, Dupont WD, Wright PF, Edwards KM. Efficacy of inactivated andcold-adapted vaccines against influenza A infection, 1985--1990: the pediatricexperience. Pediatr Infect Disease J. 2001;20:733-40.
10. Whitley RJ, Hayden FG, Reisinger KS, et al. Oral oseltamivir treatment ofinfluenza in children. Pediatr Infect Dis J. 2001;20:127-33.
11. Internet resources:
Newsletter
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
How Contaminated Is Your Stretcher? The Hidden Risks on Hospital Wheels
July 3rd 2025Despite routine disinfection, hospital surfaces, such as stretchers, remain reservoirs for harmful microbes, according to several recent studies. From high-touch areas to damaged mattresses and the effectiveness of antimicrobial coatings, researchers continue to uncover persistent risks in environmental hygiene, highlighting the critical need for innovative, continuous disinfection strategies in health care settings.
Getting Down and Dirty With PPE: Presentations at HSPA by Jill Holdsworth and Katie Belski
June 26th 2025In the heart of the hospital, decontamination technicians tackle one of health care’s dirtiest—and most vital—jobs. At HSPA 2025, 6 packed workshops led by experts Jill Holdsworth and Katie Belski spotlighted the crucial, often-overlooked art of PPE removal. The message was clear: proper doffing saves lives, starting with your own.
